Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-033116)

Filing Details

Accession Number:: 0001104659-20-033116
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-13 16:08:06
Reporting Period:: 2019-06-03

Accepted Time:: 2020-03-13 16:08:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1429260	Fortress Biotech Inc.	FBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
941841	Md A Lindsay Rosenwald	C/O Fortress Biotech, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014	President, Ceo & Chairman	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2019-06-03	1,467	$1.10	8,571,189	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2019-12-01	1,123	$2.06	8,572,312	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2020-01-01	801,536	$0.00	9,373,848	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	A	Direct

Footnotes

Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period.
The Reporting Person was granted 801,536 restricted shares pursuant to the Issuer's Long Term Incentive Plan on January 1, 2020.